Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Cardiovascular Risk Reports
Erschienen in: Current Cardiovascular Risk Reports 1/2024

22.12.2023

Assisted Reproductive Technology and Cardiovascular Risk in Women

verfasst von: Katherine Cameron, Barbara Luke, Gaya Murugappan, Valerie L. Baker

Erschienen in: Current Cardiovascular Risk Reports | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To summarize what is currently known regarding the impact of assisted reproductive technology (ART) on the cardiovascular health of women, both during treatment and long-term, and to highlight specific at-risk subgroups and treatment considerations.

Recent Findings

Women utilizing ART are already at increased risk for cardiovascular pathology, and the association between ART and adverse pregnancy outcomes makes disentangling the individual contribution of ART to CVD risk challenging. Pregnancies conceived from ART are at increased risk for several complications including maternal venous thromboembolism and hypertensive disorders. The use of frozen embryo transfer and trophectoderm biopsy for preimplantation genetic testing appear to significantly increase the risk of hypertensive disorders of pregnancy. Though limited, current available evidence suggests ART does not appear to be associated with an increased risk for long-term cardiovascular morbidity and mortality. Women with pre-existing cardiac disease require specialized care from a multi-disciplinary team but can be considered candidates for ART with use of a gestational carrier even if pregnancy is not deemed safe due to their underlying conditions.

Summary

More high-quality evidence is needed to better assess the short and long-term effects of ART on the cardiovascular health of women. ART for special populations, including those with pre-existing cardiac conditions, requires special consideration to minimize complications.
Literatur
1.
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: Final Data for 2019. Natl Vital Stat Rep. 2021;70(2):1–51.PubMed
2.
Centers for Disease Control and Prevention, 2021. 2019 assisted reproductive technology fertility clinic and national summary report. U.S. Department of Health and Human Services.
3.
Quinn MM, Cedars MI. A Canary in the Coal Mine: Reproductive Health and Cardiovascular Disease in Women. Semin Reprod Med. 2017;35(3):250–5.PubMedCrossRef
4.
Murugappan G, Li S, Alvero RJ, Luke B, Eisenberg ML. Association between infertility and all-cause mortality: analysis of US claims data. Am J Obstet Gynecol. 2021;225:57.e1-57.e11.PubMedCrossRef
5.
Murugappan G, Leonard SA, Farland LV, Lau ES, Shadyab AH, Wild RA, Schnatz P, Carmichael SL, Stefanick ML, Parikh NI. Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the Women’s Health Initiative. Fertil Steril. 2022;117(5):1038–46.PubMedPubMedCentralCrossRef
6.
•• Murugappan G, Li S, Lathi RB, Baker VL, Eisenberg ML. Increased risk of incident chronic medical conditions in infertile women: analysis of US claims data. Am J Obstet Gynecol. 2019;220(5):473.e1-473.e14. Large national insurance claims study demonstrating increased risk of cardiovascular disease in women with infertility compared to those without.PubMedCrossRef
7.
Gleason JL, Shenassa ED, Thoma ME. Self-reported infertility, metabolic dysfunction, and cardiovascular events: a cross-sectional analysis among U.S. women. Fertil Steril. 2019;111(1):138–46.PubMedCrossRef
8.
• Parikh NI, Gonzalez JM, Anderson CAM, Judd SE, Rexrode KM, Hlatky MA, Gunderson EP, Stuart JJ, Vaidya D; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021;143(18): e902-e916. Statement that summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for-gestational-age delivery, placental abruption, and pregnancy loss increase a woman’s risk of developing cardiovascular disease (CVD) risk factors and of developing subsequent CVD.
9.
Zhang J, Xu JH, Qu QQ, Zhong GQ. Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies. Front Cardiovasc Med. 2020;7:55242.CrossRef
10.
•• Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, Laven JSE, Roeters van Lennep JE, Roseboom TJ, Hoek A. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942–960. Systematic review with 23 cohort studies quantifying the increased risk of cardiometabolic disease that women with PCOS experience.
11.
Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan MH. Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births. Hum Reprod. 2020;35(8):1914–21.PubMedCrossRef
12.
Alur-Gupta S, Boland MR, Barnhart KT, Sammel MD, Dokras A. Postpartum complications increased in women with polycystic ovary syndrome. Am J Obstet Gynecol. 2021;224(3):280.e1-280.e13.PubMedCrossRef
13.
•• Farland LV, Degnan WJ 3rd, Bell ML, Kasner SE, Liberman AL, Shah DK, Rexrode KM, Missmer SA. Laparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study. Stroke. 2022:101161STROKEAHA122039250. Nurses’ Health Study II analysis demonstrating 34% increased risk of stroke in women with endometriosis with contribution of hypoestrogenic state quantified
14.
Mu F, Rich-Edwards J, Rimm EB, Spiegelman D, Forman JP, Missmer SA. Association Between Endometriosis and Hypercholesterolemia or Hypertension. Hypertension. 2017;70(1):59–65.PubMedCrossRef
15.
Chiang HJ, Lan KC, Yang YH, Chiang JY, Kung FT, Huang FJ, Lin YJ, Su YT, Sung PH. Risk of major adverse cardiovascular and cerebrovascular events in Taiwanese women with endometriosis. J Formos Med Assoc. 2021;120(1 Pt 2):327–36.PubMedCrossRef
16.
Okoth K, Wang J, Zemedikun D, Thomas GN, Nirantharakumar K, Adderley NJ. Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study. BJOG. 2021;128(10):1598–609.PubMedCrossRef
17.
•• Farland LV, Stern JE, Liu CL, Cabral HJ, Coddington CC 3rd, Diop H, Dukhovny D, Hwang S, Missmer SA. Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts. Am J Obstet Gynecol. 2022;226(6):829.e1-829.e14. Massachusetts linkage study demonstrating increased risk of hypertensive disorders of pregnancy in women with endometriosis and in women with uterine fibroids.PubMedCrossRef
18.
Lalani S, Choudhry AJ, Firth B, Bacal V, Walker M, Wen SW, Singh S, Amath A, Hodge M, Chen I. Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis. Hum Reprod. 2018;33(10):1854–65.PubMedPubMedCentralCrossRef
19.
Farland LV, Prescott J, Sasamoto N, Tobias DK, Gaskins AJ, Stuart JJ, Carusi DA, Chavarro JE, Horne AW, Rich-Edwards JW, Missmer SA. Endometriosis and Risk of Adverse Pregnancy Outcomes. Obstet Gynecol. 2019;134(3):527–36.PubMedPubMedCentralCrossRef
20.
Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–12.PubMedCrossRef
21.
Haan YC, Diemer FS, Van Der Woude L, Van Montfrans GA, Oehlers GP, Brewster LM. The risk of hypertension and cardiovascular disease in women with uterine fibroids. J Clin Hypertens (Greenwich). 2018;20(4):718–26.PubMedCrossRef
22.
23.
Fujitake E, Jaspal R, Monasta L, Stampalija T, Lees C. Acute cardiovascular changes in women undergoing in vitro fertilisation (IVF), a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;248:245–51.PubMedCrossRef
24.
Quien MM, Hausvater A, Maxwell SM, Weinberg CR. Assisted Reproductive Technology Outcomes in Women With Heart Disease. Front Cardiovasc Med. 2022;9: 842556.PubMedPubMedCentralCrossRef
25.
Smith J, Velez MP, Dayan N. Infertility, Infertility Treatment, and Cardiovascular Disease: An Overview. Can J Cardiol. 2021;37:1959–68.PubMedCrossRef
26.
Levi-Setti PE, Di Segni N, Gargasole C, Ronchetti C, Cirillo F. Ovarian Hyperstimulation: Diagnosis, Prevention, and Management. Semin Reprod Med. 2021;39(5–06):170–9.PubMed
27.
Kim YY, Levine LD, Partington SL, Patel PA, Ruckdeschel E, Senapati S, Gracia CR. Successful in vitro fertilization in women with Fontan physiology. J Assist Reprod Genet. 2020;37(12):3017–23.PubMedPubMedCentralCrossRef
28.
Thunström S, Krantz E, Thunström E, Hanson C, Bryman I, Landin-Wilhelmsen K. Incidence of Aortic Dissection in Turner Syndrome. Circulation. 2019;139(24):2802–4.PubMedCrossRef
29.
Grewal J, Valente AM, Egbe AC, Wu FM, Krieger EV, Sybert VP, van Hagen IM, Beauchesne LM, Rodriguez FH, Broberg CS, John A, Bradley EA, Roos-Hesselink JW, AARCC Investigators. Cardiovascular outcomes of pregnancy in Turner syndrome. Heart. 2021;107(1):61–6.PubMedCrossRef
30.
Jacobsen AF, Sandset PM. Prior thromboembolic disease and assisted reproductive therapy. Semin Reprod Med. 2021;39(5–06):180–5.PubMed
31.
Sennström M, Rova K, Hellgren M, Hjertberg R, Nord E, Thurn L, Lindqvist PG. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand. 2017;96(9):1045–52.PubMedCrossRef
32.
Olausson N, Discacciati A, Nyman AI, Lundberg F, Hovatta O, Westerlund E, Wallén HN, Mobarrez F, Bottai M, Ekbom A, Henriksson P. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: Nationwide cohort study. J Thromb Haemost. 2020;18(8):1965–73.PubMedCrossRef
33.
• Wu P, Sharma GV, Mehta LS, Chew-Graham CA, Lundberg GP, Nerenberg KA, Graham MM, Chappell LC, Kadam UT, Jordan KP, Mamas MA. In-Hospital Complications in Pregnancies Conceived by Assisted Reproductive Technology. J Am Heart Assoc. 2022;11(5): e022658. National Inpatient Sample database study demonstrating increased risk of kidney injury and arrhythmias in over 100,000 ART pregnancies.PubMedPubMedCentralCrossRef
34.
Conrad KP, von Versen-Höynck F, Baker VL. Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia risk. Am J Obstet Gynecol. 2022;226:683–99.PubMedCrossRef
35.
Almasi-Hashiani A, Omani-Samani R, Mohammadi M, Amini P, Navid B, Alizadeh A, Khedmati Morasae E, Maroufizadeh S. Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):149.PubMedPubMedCentralCrossRef
36.
•• Chih HJ, Elias FTS, Gaudet L, Velez MP. Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses. BMC Pregnancy Childbirth. 2021;21(1):449. Systematic review and meta-analysis including 85 studies demonstrating 70% increased risk of hypertensive disorders of pregnancy in pregnancies conceived using IVF, particularly in frozen compared to fresh embryo transfer.PubMedPubMedCentralCrossRef
37.
Pelikh A, Smith KR, Myrskylä M, Goisis A. Medically Assisted Reproduction Treatment Types and Birth Outcomes: A Between-Family and Within-Family Analysis. Obstet Gynecol. 2022;139(2):211–22.PubMedPubMedCentralCrossRef
38.
Manna C, Lacconi V, Rizzo G, De Lorenzo A, Massimiani M. Placental Dysfunction in Assisted Reproductive Pregnancies: Perinatal, Neonatal and Adult Life Outcomes. Int J Mol Sci. 2022;23(2):659.PubMedPubMedCentralCrossRef
39.
Luke B, Brown MB, Eisenberg ML, Callan C, Botting BJ, Pacey A, Sutcliffe AG, Baker VL. In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters. Am J Obstet Gynecol. 2020;222(4):350.e1-350.e13.PubMedCrossRef
40.
•• Petersen S, Westvik-Johari K, Spangmose A, Pinborg A, Bergh C, Gissler M, Tiitinen A, Wennerholm U, Åsvold B, Romundstad L, Opdahl S. O-273 Risk of hypertensive disorders in pregnancy after fresh and frozen embryo transfer in assisted reproduction: A population-based cohort study with within sibship analysis. Hum Reprod. 2022;37 (Supplement_1). Analysis of 4.5 million pregnancies in Denmark, Norway, and Sweden demonstrating increased risk of hypertensive disorder of pregnancy in women undergoing FET, but not fresh transfer compared to pregnancies conceived without ART, including within sibship comparisons.
41.
Conrad KP, von Versen-Höynck F, Baker VL. Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia risk. Am J Obstet Gynecol. 2022;226(5):683–99.PubMedCrossRef
42.
43.
von Versen-Höynck F, Strauch NK, Liu J, Chi YY, Keller-Woods M, Conrad KP, Baker VL. Effect of mode of conception on maternal serum relaxin, creatinine, and sodium concentrations in an infertile population. Reprod Sci. 2019;26:412–9.CrossRef
44.
Wiegel RE, Jan Danser AH, Steegers-Theunissen RPM, Laven JSE, Willemsen SP, Baker VL, Steegers EAP, von Versen-Höynck F. Determinants of maternal renin-angiotensin-aldosterone-system activation in early pregnancy: insights from 2 cohorts. J Clin Endocrinol Metab. 2020;105:3505–17.PubMedPubMedCentralCrossRef
45.
von Versen-Höynck F, Schaub AM, Chi YY, Chiu KH, Liu J, Lingis M, Stan Williams R, Rhoton-Vlasak A, Nichols WW, Fleischmann RR, Zhang W, Winn VD, Segal MS, Conrad KP, Baker VL. Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;73:640–9.CrossRef
46.
•• Wu H, Zhou P, Lin X, Wang S, Zhang S. Endometrial preparation for frozen-thawed embryo transfer cycles: a systematic review and network meta-analysis. J Assist Reprod Genet. 2021;38(8):1913–26. Meta-analysis of 26 RCTs and 113 cohort studies comparing risk of HDP based on frozen embryo transfer protocol, demonstrating increased risk (OR 1.82) for protocols that do not result in a corpus luteum.PubMedPubMedCentralCrossRef
47.
Asserhøj LL, Spangmose AL, Aaris Henningsen AK, Clausen TD, Ziebe S, Jensen RB, Pinborg A. Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET. Fertil Steril. 2021;115:947–56.PubMedCrossRef
48.
49.
Zhang J, Wei M, Bian X, Wu L, Zhang S, Mao X, Wang B. Letrozole-induced frozen embryo transfer cycles are associated with a lower risk of hypertensive disorders of pregnancy among women with polycystic ovary syndrome. Am J Obstet Gynecol. 2021;225(1):59.e1-59.CrossRef
50.
Singh B, Reschke L, Segars J, Baker VL. Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications. Fertil Steril. 2020;113:252–7.PubMedPubMedCentralCrossRef
51.
Pohjonen EM, Söderström-Anttila V, Bergh C, Loft A, Magnusson Å, Pinborg A, Oldereid NB, Petzold M, Romundstad LB, Laivuori H. Obstetric and perinatal risks after the use of donor sperm: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022;274:210–28.PubMedCrossRef
52.
Micelli E, Fatini C, Ralli E, Cirillo M, Romanelli C, Badolato L, Basile V, Picone R, Orlandi G, Giachini C, Evangelisti P, Fucci R, Cito G, Rizzello F, Coccia ME. Cardiometabolic and Thrombotic Risk Profile in Women Undergoing Oocyte Donation for Assisted Reproduction. J Womens Health (Larchmt). 2021;30(5):758–64.PubMedCrossRef
53.
Zhang WY, von Versen-Höynck F, Kapphahn KI, Fleischmann RR, Zhao Q, Baker VL. Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril. 2019;112:283–90.PubMedPubMedCentralCrossRef
54.
•• Zheng W, Yang C, Yang S, Sun S, Mu M, Rao M, Zu R, Yan J, Ren B, Yang R, Guan Y. Obstetric and neonatal outcomes of pregnancies resulting from preimplantation genetic testing: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(6):989–1012. Meta-analysis demonstrating pregnancies conceived after trophectoderm biopsy have increased risk for HDP (HR 1.52).PubMedCrossRef
55.
Hou W, Shi G, Ma Y, Liu Y, Lu M, Fan X, Sun Y. Impact of preimplantation genetic testing on obstetric and neonatal outcomes: a systematic review and meta-analysis. Fertil Steril. 2021;116(4):990–1000.PubMedCrossRef
56.
57.
Severino AI, Póvoa AM. Frozen Embryo Transfer and Preeclampsia Risk. J Gynecol Obstet Hum Reprod. 2021;50(9): 102167.PubMedCrossRef
58.
Baksh S, Casper A, Christianson MS, Devine K, Doody KJ, Ehrhardt S, Hansen KR, Lathi RB, Timbo F, Usadi R, Vitek W, Shade DM, Segars J, Baker VL, NatPro Study Group. Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trial. Trials. 2021;22:660.PubMedPubMedCentralCrossRef
59.
Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T, Basso O, Udell JA. Cardiovascular Risk Following Fertility Therapy: Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2017;5(70):1203–13.CrossRef
60.
Bonetti NR, Meister TA, Soria R, Akhmedov A, Liberale L, Ministrini S, Dogar A, Lüscher TF, Messerli FH, Rexhaj E, Camici GG, Beer JH, Scherrer U. In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice. Int J Cardiol. 2021;343:92–101.PubMedCrossRef
61.
62.
Farland LV, Liu CL, Diop H, Cabral HJ, Missmer SA, Coddington CC, Hwang SS, Stern JE. Hospitalizations up to 8 years following delivery in assisted reproductive technology-treated and subfertile women. Fertil Steril. 2022;117(3):593–602.PubMedPubMedCentralCrossRef
63.
Vassard D, Schmidt L, Pinborg A, Petersen GL, Forman JL, Hageman I, Glazer CH, Kamper-Jørgensen M. Mortality in women treated with assisted reproductive technology-addressing the healthy patient effect. Am J Epidemiol. 2018;187(9):1889–95.PubMedCrossRef
64.
Coddington CC, Gopal D, Cui X, Cabral H, Diop H, Stern JE. Influence of subfertility and assisted reproductive technology treatment on mortality of women after delivery. Fertil Steril. 2020;113:569-577.e1.PubMedPubMedCentralCrossRef
Metadaten
Titel
Assisted Reproductive Technology and Cardiovascular Risk in Women
verfasst von
Katherine Cameron
Barbara Luke
Gaya Murugappan
Valerie L. Baker
Publikationsdatum
22.12.2023
Verlag
Springer US
Erschienen in
Current Cardiovascular Risk Reports / Ausgabe 1/2024
Print ISSN: 1932-9520
Elektronische ISSN: 1932-9563
DOI
https://doi.org/10.1007/s12170-023-00732-3

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise